A molecular basis for the different local anesthetic affinities of resting versus open and inactivated states of the sodium channel.

Voltage-gated sodium channels are inhibited by local anesthetic drugs. This inhibition has complex voltage- and frequency-dependent properties, consistent with a model in which the sodium channel has low affinity for local anesthetics when it is in resting states and higher affinity when it is in open or inactivated states. Two residues, a phenylalanine (F1710) and a tyrosine (Y1717), in transmembrane segment IVS6 of the channel alpha subunit are critical for state-dependent block. We examined how these residues determine channel sensitivity to local anesthetics by introducing mutations that varied their size, hydrophobicity, and aromaticity. Block of resting channels by tetracaine was correlated with hydrophobicity at position 1710, as if hydrophobic drug-receptor interactions stabilize binding to resting states. In contrast, drug action on open or inactivated channels required an aromatic residue at this position. We propose that the native phenylalanine at position 1710 stabilizes drug binding to open or inactivated states by either cation-pi or aromatic-aromatic interactions between the aromatic side chain of the amino acid and charged or aromatic moieties on the drug molecule. We also consider the alternative possibility that mutations at this position affect drug action by either altering access to the receptor or by allosteric changes in receptor conformation. Mutations at position 1717 also altered drug action; however, these effects were not well-correlated with the size, hydrophobicity, or aromaticity of the substituted amino acid. These results suggest that the residue at this position does not contribute directly to the drug receptor.

[1]  R. Tsien,et al.  Preferential Interaction of ω-Conotoxins with Inactivated N-type Ca2+ Channels , 1997, The Journal of Neuroscience.

[2]  M. Noda,et al.  Differential regulation of three sodium channel messenger RNAs in the rat central nervous system during development. , 1989, The EMBO journal.

[3]  W. Catterall,et al.  The sodium channel from rat brain , 1986 .

[4]  B. Roth,et al.  Differential ergoline and ergopeptine binding to 5-hydroxytryptamine2A receptors: ergolines require an aromatic residue at position 340 for high affinity binding. , 1995, Molecular pharmacology.

[5]  G. Strichartz,et al.  The Inhibition of Sodium Currents in Myelinated Nerve by Quaternary Derivatives of Lidocaine , 1973, The Journal of general physiology.

[6]  W. Catterall Common modes of drug action on Na+ channels: local anesthetics, antiarrhythmics and anticonvulsants , 1987 .

[7]  S G Waxman,et al.  Sodium channel mRNAs I, II and III in the CNS: cell-specific expression. , 1994, Brain research. Molecular brain research.

[8]  W. Catterall,et al.  The sodium channel from rat brain. Purification and subunit composition. , 1984, The Journal of biological chemistry.

[9]  B. Chait,et al.  The structure of the potassium channel: molecular basis of K+ conduction and selectivity. , 1998, Science.

[10]  W. Catterall,et al.  Common molecular determinants of local anesthetic, antiarrhythmic, and anticonvulsant block of voltage-gated Na+ channels. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Francisco Bezanilla,et al.  Charge Movement Associated with the Opening and Closing of the Activation Gates of the Na Channels , 1974, The Journal of general physiology.

[12]  Y. Jan,et al.  Evidence that the S6 segment of the Shaker voltage-gated K+ channel comprises part of the pore , 1994, Nature.

[13]  K. Gingrich,et al.  Ultra‐deep blockade of Na+ channels by a quaternary ammonium ion: catalysis by a transition‐intermediate state? , 1993, The Journal of physiology.

[14]  M. Avoli,et al.  Sodium channels as molecular targets for antiepileptic drugs , 1998, Brain Research Reviews.

[15]  A. Brown,et al.  Comparison of H5, S6, and H5-S6 exchanges on pore properties of voltage-dependent K+ channels. , 1994, The Journal of biological chemistry.

[16]  B. Hille Ionic channels of excitable membranes , 2001 .

[17]  V. Flockerzi,et al.  Primary structure of rat brain sodium channel III deduced from the cDNA sequence , 1988, FEBS letters.

[18]  C. Post,et al.  Structure-activity relationship of lidocaine homologs producing tonic and frequency-dependent impulse blockade in nerve. , 1986, The Journal of pharmacology and experimental therapeutics.

[19]  G. Yellen,et al.  Gated Access to the Pore of a Voltage-Dependent K+ Channel , 1997, Neuron.

[20]  A. VanDongen,et al.  Toxin and kinetic profile of rat brain type III sodium channels expressed in Xenopus oocytes. , 1990, Brain research. Molecular brain research.

[21]  B. Katzung,et al.  Time- and voltage-dependent interactions of antiarrhythmic drugs with cardiac sodium channels. , 1977, Biochimica et biophysica acta.

[22]  W. Catterall,et al.  Cellular and molecular biology of voltage-gated sodium channels. , 1992, Physiological reviews.

[23]  D. A. Dougherty,et al.  Cation-π Interactions in Chemistry and Biology: A New View of Benzene, Phe, Tyr, and Trp , 1996, Science.

[24]  A. Karlin,et al.  Toward a structural basis for the function of nicotinic acetylcholine receptors and their cousins , 1995, Neuron.

[25]  R. MacKinnon,et al.  The aromatic binding site for tetraethylammonium ion on potassium channels , 1992, Neuron.

[26]  K. Courtney Structure-activity relations for frequency-dependent sodium channel block in nerve by local anesthetics. , 1980, The Journal of pharmacology and experimental therapeutics.

[27]  G A Petsko,et al.  Aromatic-aromatic interaction: a mechanism of protein structure stabilization. , 1985, Science.

[28]  A. Goldman,et al.  Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine-binding protein , 1991, Science.

[29]  R. French,et al.  Amine blockers of the cytoplasmic mouth of sodium channels: a small structural change can abolish voltage dependence. , 1994, Biophysical journal.

[30]  M. Taouis,et al.  Aminoalkyl structural requirements for interaction of lidocaine with the class I antiarrhythmic drug receptor on rat cardiac myocytes. , 1991, Molecular pharmacology.

[31]  K. R. Woods,et al.  Prediction of protein antigenic determinants from amino acid sequences. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[32]  B. Hille,et al.  Local anesthetics: hydrophilic and hydrophobic pathways for the drug- receptor reaction , 1977, The Journal of general physiology.

[33]  W. Almers,et al.  Interactions between quaternary lidocaine, the sodium channel gates, and tetrodotoxin. , 1979, Biophysical journal.

[34]  P. Bennett,et al.  On the molecular nature of the lidocaine receptor of cardiac Na+ channels. Modification of block by alterations in the alpha-subunit III-IV interdomain. , 1995, Circulation research.

[35]  A L Goldin,et al.  The adult rat brain beta 1 subunit modifies activation and inactivation gating of multiple sodium channel alpha subunits. , 1994, The Journal of biological chemistry.

[36]  W. Catterall,et al.  Molecular determinants of state-dependent block of Na+ channels by local anesthetics. , 1994, Science.

[37]  S. Barik Site-directed mutagenesis by double polymerase chain reaction : megaprimer method. , 1993, Methods in molecular biology.